Outcomes of the Board Meeting held on 12th November, 2025 for approval of Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Narmada Gelatines Limited met on November 12, 2025, from 12:00 pm to 12:55 pm, and approved the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2025. This is a routine regulatory disclosure under SEBI Listing Regulations, confirming that the company's Q2 and first-half FY26 results have been cleared by the Board. No specific financial figures, profitability numbers, or exceptional items have been disclosed in this intimation.
This is a standard procedural filing with no direct impact on the stock price. Investors should review the actual Q2/H1 results document for revenue, profit, and margin trends before drawing any conclusions.